CNBC's Jim Cramer on Friday told investors what to follow next week as earnings season kicks off, highlighting reports from JPMorgan, Netflix, Goldman Sachs and PepsiCo. "Once we process the new tariffs, we've got a ton of earnings reports coming next week, so you better keep your eyes open," he said. Tuesday brings earnings from financial giants JPMorgan, Wells Fargo, Citigroup and BlackRock, and Cramer said he'll be waiting to hear whether there has been any slowdown in spending or pick up in loan losses. ...

Public Keys: Core Scientific and CoreWeave announce a massive $9 billion merger while Bitcoin ETFs see their second-biggest day ever with $1.17 billion in inflows.Read more: https://t.co/eCmvsf4WrM ...

Legendary Entertainment may be looking to acquire Lionsgate Studios, which has just spun off on its own ticker on Wall Street. Lionsgate split itself up, Starz going one way, Lionsgate Studios, the other so that either or both could be primed for M&A. We’re getting word that Moelis & Company investment bank is involved with the early talks here. What’s clear is that Lionsgate and Legendary are having conversations on a couple of feature co-productions. That’s bound to be the litmus test in regards to seein ...

I hear from CEOs who were excited about this administration coming in. They thought that this was going to open the door for mergers and acquisitions, that the FTC was going to be more progressive, more open-minded, and now they're not engaging in mergers and acquisitions because of the uncertainty and the volatility around tariffs. If the tariffs were to be implemented at exactly what the promise is coming out of the White House, would that be better than than the uncertainty surrounding it.Uh potentially ...

About Inmagene Biopharmaceuticals Inmagene is a global clinical-stage biotechnology company developing novel therapeutics for immunological and inflammatory (I&I) diseases. The company's highly differentiated clinical-stage pipeline has multiple candidates with best-in-class potential. The lead asset IMG-007, a nondepleting anti-OX40 mAb, recently completed a Phase 2a clinical trial in atopic dermatitis. For more information, please visit www.inmagenebio.com. About Ikena Oncology BOSTON, July 11, 2025 (GLOB ...

A little-known Japanese elevator stock has surged nearly 6,000% — by buying up heirless family-run firms https://t.co/XDhFiTZ348 ...

Goldman Sachs has promoted Ben Wallace as co-head of mergers and acquisitions in the Americas https://t.co/eZnr7GEr5A ...

SANDUSKY, Ohio and SPENCER, Ohio, July 10, 2025 /PRNewswire/ -- Sandusky, Ohio based Civista Bancshares, Inc. ("Civista") (NASDAQ: CIVB) and The Farmers Savings Bank ("Farmers") today announced the signing of a definitive merger agreement pursuant to which Civista will acquire Farmers. Based on financial data as of March 31, 2025, the combined company would have total assets of approximately $4.4 billion, total net loans of approximately $3.2 billion and total deposits of approximately $3.5 billion.Civista ...

Group 1: Acquisition Details - WK Kellogg has agreed to be acquired by Ferrero for approximately $3.1 billion, amid challenges from weakening consumer demand due to high inflation [1] - Ferrero has offered WK Kellogg's shareholders $23 per share, which represents a 31% premium over the stock's last closing price [2][5] - The acquisition is Ferrero's largest in recent years and will consolidate brands like Nutella, Kinder, and Frosted Flakes under one umbrella [3][7] Group 2: Market Context - The snacking sector is experiencing increased deal-making activity as food brands face muted sales following price hikes driven by higher input costs and a shift towards healthier options [1][7] - WK Kellogg and other packaged food companies, including J.M. Smucker and Kraft Heinz, have reported subdued demand due to cautious consumer spending in the U.S. [7][10] - WK Kellogg's projected second-quarter net sales are expected to be between $610 million and $615 million, falling short of analysts' average estimate of $653.7 million [8] Group 3: Company Background - WK Kellogg was spun off from Kellanova and represents the North American cereal business of Kellogg, the original parent company [4] - Kellanova, the maker of Cheez-It, is also in the process of being acquired by Mars in a deal valued at nearly $36 billion [4] - Ferrero has expanded significantly through acquisitions, including the purchase of Nestle's U.S. confectionery business for $2.8 billion in 2018, and reported revenue of €18.4 billion ($19.2 billion) for the financial year ending August 31 [9]

Key Takeaways DNBBY is set to report Q2 results, with NII likely pressured by lower deposit margins. A rebound in mergers and acquisitions can support modest gains in DNBBY's investment banking revenues. Elevated personnel, benefits and restructuring costs are expected to weigh on DNBBY's Q2 expense base.DNB Bank ASA (DNBBY) is slated to announce second-quarter 2025 results tomorrow.In the last reported quarter, this Zacks Rank #3 (Hold) stock reported an increase in net interest income (NII), as well as ...